RHUMBLINE ADVISERS - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 59 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.54 and the average weighting 0.7%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$54,000
-29.9%
52,701
+6.5%
0.00%
Q4 2019$77,000
-16.3%
49,493
-2.5%
0.00%
Q3 2019$92,000
+16.5%
50,786
+5.0%
0.00%
Q2 2019$79,00048,3790.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ESSEX INVESTMENT MANAGEMENT CO LLC 1,136,282$2,148,0000.17%
EAM Investors, LLC 237,409$449,0000.12%
BARD ASSOCIATES INC 89,559$169,0000.10%
HighTower Advisors, LLC 5,260,088$9,942,0000.08%
Kore Private Wealth LLC 75,866$143,0000.04%
Regal Investment Advisors LLC 69,950$132,0000.03%
Paragon Capital Management Ltd 24,750$47,0000.02%
Alpine Global Management, LLC 45,994$87,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 67,204$127,0000.02%
BlueCrest Capital Management Ltd 113,480$214,0000.01%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders